Skip to main content


  • Review
  • Open Access

Germ-line transmission of trisomy 21: Data from 80 families suggest an implication of grandmaternal age and a high frequency of female-specific trisomy rescue

Molecular Cytogenetics20103:7

  • Received: 14 October 2009
  • Accepted: 18 March 2010
  • Published:



Trisomy of chromosome 21 (T21; Down syndrome, DS) is the most common aneuploidy in live births. Though its etiology has been intensively studied for a half of century, there are surprisingly many problems awaiting their elucidation. Some of the open questions are related directly to germ line mosaicism for T21, other problems include the prevalence of males with non-mosaic trisomy over females (skewed sex ratio, SR), the genetic predisposition to non-disjunction, etc. Studies in families of gonadal mosaicism (GM) carriers might help resolving some of these problems.


80 families of carriers of GM, in which the sex of the offspring had been specified, were identified in the literature and in logbooks of two local genetic units. Mothers in these families were relatively young: only 8% of mothers were 35 years old and older at the time of delivery of their first affected offspring while the proportion of grandmothers on the GM carrier's side aged 35 years old and older was significantly higher (39%). Postzygotic rescue of T21 due to error in the meiosis I had been proposed as a mechanism of parental GM formation in 78% of the families with known origin of the T21. For the other 22%, rescue of errors in the meiosis II or postzygotic mitotic non-disjunction was assumed. Mosaicism for T21 in successive generations was reported in at least 12 families. The proportion of mosaics among affected female offspring (14%) is significantly higher compared to that among affected male offspring (0%). Male preponderance (SR = 1.5) is found in non mosaic liveborn offspring with either maternally- or paternally transmitted T21. Among unaffected offspring of male carriers of GM there is a notable excess of females (SR = 0.27).


Both direct (results of cytogenetic and molecular study of the origin of trisomic line) and indirect (advanced grandmaternal age on the side of GM carrier) evidences allow to assume that significant proportion of the mosaic parents had been conceived as trisomics. Female-specific trisomy rescue and genetic predisposition to postzygotic non-disjunction has been suggested as mechanisms of formation of both GM and somatic mosaicism. Typical male preponderance in affected non mosaic offspring with either maternally- or paternally transmitted trisomy 21, indicates than meiotic events are not responsible for the skewed sex ratio in DS. However a female excess among unaffected offspring of male carriers of GM might be the result of meiotic non homologous co-orientation of chromosomes 21 and X in spermatogenesis.


  • Down Syndrome
  • Male Carrier
  • Affected Offspring
  • Germ Line Mosaicism
  • Male Excess


Trisomy of chromosome 21 (T21; Down syndrome, DS) is the most common aneuploidy in livebirths [1]. Though its etiology has been intensively studied for almost half a century, there are surprisingly many problems awaiting their elucidation [2]. Some of the open questions are related directly to germ line mosaicism (including precise evaluation the contribution of parental mosaicism to the occurrence of DS cases, the timing of mosaicism formation and the underlying mechanisms) [3, 4]. Other problems are the genetic predisposition to non-disjunction (NDJ) [5], the effect of endogenous factors and environmental exposures, the prevalence of males with non-mosaic trisomy over females [6]. Studies in families of gonadal mosaicism (GM) carriers might help to resolve some of these problems.

Non-mosaic free T21 is mostly a result of NDJ in oogenesis. The majority of maternally derived trisomies occur in meiosis I, meiosis II errors only constitute about 20% of maternal errors. Paternally derived trisomies are several times less frequent and display about an equal number of errors in meiosis I and meiosis II. In about 4% of trisomic individuals, the additional chromosome appears to result from postzygotic error [7]. In a collective sample of 53 affected individuals with mosaic T21, somewhat different proportions were found, with a higher contribution of paternally derived extra chromosome (24%) and a higher rate (42%) of NDJ in meiosis II and mitotic NDJ in a normal euploid zygote [8]. Whether the contribution of different mechanisms to the formation of a trisomic line in asymptomatic GM carriers is different from that in affected individuals is still to be investigated.

There are few widely cited reports of mosaicism for T21 in two successive generations in one family [911] suggesting genetic predisposition to NDJ. Large samples are needed to confirm a genetic predisposition and to shed light on the underlying mechanism.

A study on the male to female ratio (sex ratio, SR) in individuals with maternally transmitted T21 might help to elucidate the phenomenon of the male prevalence among patients with DS. Male excess in DS patients with non-mosaic T21 is a well known but poorly understood phenomenon. The sex ratio varies in different populations, being close to average 1.3. Several hypotheses have been put forward to explain the skewed SR in DS. Meiotic disturbance (non-homologous co-orientation in male meiosis) [12, 13], fertilization event (greater accessibility of Y-bearing sperm to ova disomic for chromosome 21 or promotion of non-disjunction in the ova by Y-bearing sperm) [1416], and post-fertilization events (intrauterine selection against females) [17, 18] have been discussed. Since females produce only X-bearing gametes, an approach to the problem may be the comparison of SR in cases of maternal and paternal transmission of T21.

Some earliest publications suggested that the risk for Down syndrome may be related to an aging grandmother [19, 20]. Since then, not many studies on parental and gradparental ages in families of carriers of GM were reported. As expected, mean maternal age at birth of their DS children was found to be similar to that at the birth of a normal baby. However, the mean grandmaternal age at the birth of the mosaic parents was significantly higher than that at the birth of trisomic DS [2123]. These studies supported a suggestion that most or all mosaic parents arose from trisomic zygotes [20]. To confirm this suggestion, more data on association of grandparental ages and grandparental origin of the mosaicism are needed.

The objectives of this study were: (1) to estimate the contribution of different mechanisms to the origin of germ line mosaicism; (2) to determine the prevalence of "inherited" mosaicism; (3) to study the sex ratio in affected offspring with respect to the mode of ascertainment and the parent of origin; (4) to study the sex ratio in unaffected offspring; and (5) to study maternal and grandmaternal ages in families of carriers of gonadal nosaicism.


Families with maternal trisomy 21 gonadal mosaicism

Table S1 (see Additional file 1: Details of families with maternal trisomy 21 gonadal mosaicism) presents the data collected from reports on parental GM for T21. In total, 61 families were identified where the mother was a carrier of germ mosaicism, with 114 affected offspring for whom the sex was specified. Among the affected offspring, there were 50 males and 34 females (SR = 1.5) postnatally diagnosed as DS (including six patients with clinical diagnosis), 13 male and 12 female fetuses with prenatally diagnosed trisomy 21 (SR = 1.08), and 2 male and 3 female miscarried fetuses with T21. Six in 108 affected individuals/fetuses with confirmed T21 (5.6%) were found to be mosaic for a normal cell line. All of them were females. Among unaffected siblings, there were 19 males and 16 females.

In about half of the cases, maternal GM was inferred from the presence of a trisomic line in a single somatic tissue. In 15 cases, mosaicism found in blood cells was confirmed in cultured skin fibroblasts. In eight instances, a trisomic line was detected in an ovarian tissue, and in one case it was found in oocytes. In one remarkable case, maternal mosaicism was identified because of maternal cell contamination of an amniotic fluid specimen from a normal male pregnancy (Additional File 1: Table S1, case 53). In six cases, GM was uncovered by DNA analysis. Maternal origin of T21 in the affected offspring was proven in 15 families. In the majority of the informative cases (9/11), the study results were consistent with the original trisomy in the mother due to NDJ in first meiotic division followed by loss of one chromosome 21 (rescue of trisomy MI, for simplicity) as a mechanism of formation of germ-line mosaicism. In two families, the study results suggested that the origin of maternal mosaicism was either postzygotic mitotic or second meiotic division NDJ (rescue of trisomy MII). And in two families, the origin of maternal mosaicism was not clarified. In two nuclear families from the same pedigree (Additional File 1: Table S1, cases 2, 3) and in two other cases (Additional File 1: Table S1, cases 7, 61) the trisomy in the carriers was most probably inherited (rescue of transmitted trisomy).

Information on the maternal age at the time of delivery of their first affected offspring was available for 54 families. Two cases from surveys on prevalence of mosaicism in young parents (Additional File 1: Table S1, cases 14, 34) were excluded from the analysis of maternal age. The great majority of the mothers were young at the time of conception/delivery of their first affected offspring, the proportion of mothers aged 35 year and older was 3 out of 52 (5.8%).

Families with paternal trisomy 21 gonadal mosaicism

Among 28 offspring in 19 families where the father was reported to be a carrier of T21 mosaicism (Additional File 2: Table S2, Details of families with paternal trisomy 21 gonadal mosaicism), there were 16 males and 10 females with postnatally diagnosed T21 (including one patient with clinical diagnosis), one prenatally detected female fetus, and one miscarried female fetus. Three out of 27 cytogenetically confirmed T21 cases displayed mosaicism for a normal cell line, two of them were females and one was non-DS male child with xeroderma pigmentosum. Three male and 11 female siblings were either normal or diagnosed as non-DS (SR = 0.27).

In the majority of the cases, paternal GM was inferred from the presence of trisomic cells in cultured blood cells. In two cases, mosaicism was detected in other tissue(s). A paternal origin of the extra chromosome 21 in the trisomic offspring was confirmed in four families, indicating a probable trisomy MI rescue in two carriers of GM and probable MII NDJ or postzygotic mitotic origin in one carrier; and in one case molecular analysis failed to define the mechanism resulting in T21 cell line.

Information on the maternal age at the time of delivery of their first affected offspring was available for 16 families. However three cases from a survey on prevalence of mosaicism in young parents (Additional File 2: Table S2, cases 3 - 5) were excluded from the analysis of maternal age. In this group, two in 13 mothers were aged 35 years and older.

Total sample (all families with either maternal or paternal trisomy 21 gonadal mosaicism)

Overall, there were 61 families with maternal GM for T21 and 19 families with paternal GM for T21, indicating a strong female prevalence among carriers of GM. Among 80 families, there were reported 12 families showing mosaicism for T21 in successive generations. They included seven families with eight affected/miscarried carriers (Additional File 1: Table S1, cases 5, 26, 43, 46, 51, and Additional File 2: Table S2, cases 16 and 19), a family with one mosaic non-DS child (Additional File 2: Table S2, case 1), and four families with asymptomatic carriers of GM (Additional File 1: Table S1, cases 2, 3, 7, 61).

Among apparently transmitted cases of T21, there were more males than females among postnatally diagnosed individuals (66 M/44 F, SR = 1.5), no significant male prevalence among prenatally diagnosed cases (13 M/12 F, SR = 1.08) and female excess among miscarried fetuses (2 M/4 F, SR = 0.5). However, because of the limited sample, the difference does not reach statistical significance.

Nine of 134 (6.7%) individuals with confirmed T21 were mosaics for a normal cell line. In this group, there were one male with no clinical features of DS (Additional File 2: Table S2, case 1) and eight affected females (Additional File 1: Table S1, cases 5, 26, 43, 46, 51, and Additional File 2: Table S2, cases 16 and 19). The male to female ratio in this group is different from both the SR = 1.06 in the general population and from SR = 1.3 typical for T21 patients (p = 0.0158 and p = 0.0071, respectively). Therefore, the proportion of mosaics among affected females (8/59 = 14%) differs significantly from 0, the proportion found among 76 affected males (p = 0.005).

Of 14 families where the origin of the T21 in the GM carrier was traced, trisomy MI rescue was suggested as a mechanism of formation of parental GM in 78% (11/14). Rescue of trisomy MII or postzygotic mitotic origin were suggested in three cases. In four families with mosaicism in successive generations, the T21 in the carrier was most probably the result of the rescue of transmitted trisomy.

Mothers were young in either parental group, and mean maternal age in the combined group was 26.4 yr, with proportion of mothers aged 35 years and older being 5/65 = 8%. There were 51 families for which a sufficient reproductive history and pregnancy outcome were known. In 17 of these families, the first born DS child/fetus was not the first born child/fetus (Additional File 1: Table S1, cases 8, 10, 18, 20, 25, 27, 36, 38, 49, 51, 53, 59, 61, and Additional File 2: Table S2, cases 8, 9, 11, 14). In this group, the proportion of mothers aged 35 years and older at the time of DS birth was 6%, and mean maternal age was 28.4 yr. The analysis of grandmaternal age, however, showed a large proportion (9/23 = 39%) of them aged 35 yr and older at the time of the birth of their GM offspring.


Mechanisms of germ mosaicism formation

Two different mechanisms are responsible for the formation of mosaicism. One is a mitotic error in a normal, euploid zygote resulting in a mosaic embryo having 46/47,+21 karyotype, the 45,-21 cell line being nonviable. Recently, it was demonstrated that mitotic errors of chromosome 21 are associated with non-viability of preimplantation embryo [24]. This most likely can be explained by the presence of nonvialble monosomic line. According to data on assessment mosaicism in human IVF embryo, > 3/8 of abnormal/removed blastomeres is considered detrimental for embryo survival [25].

The other mechanism is a NDJ in parental gametogenesis followed by an early postzygotic malsegregation of chromosome 21 ("trisomy rescue"). There are two mechanisms of chromosome malsegregation in a trisomic conceptus, chromosome loss and NDJ, the latter resulting in a mosaic embryo with a 46/47,+21/48,+21,+21 karyotype. In vitro studies in binucleated lymphocytes of trisomy 21 patients and of healthy children showed that the frequency of NDJ was significantly higher than the loss of chromosome 21. Moreover, malsegregation of chromosome 21 occurs more often in trisomic 21 cells than in disomic cells from normal children [26]. Although very rarely, some few cases of mosaicism for a tetrasomic line were found in prenatal samples [27].

It was suggested that the presence of a tetrasomic line in the gonads of a carrier of GM mosaicism might explain some cases of extraordinary occurrence of several conceptions of trisomy 21 in a one sibship [2831]. It should be noted though, that no tetrasomic cells were reported in published studies on ovaries of carriers of GM [9, 28, 3236]. Another underlying mechanism of a high recurrence of trisomic offspring in some families was proposed recently [4]. This mechanism suggests a specific type of secondary non-disjunction in a T21 oocyte by formation of either a trivalent or a bivalent plus univalent.

As stated in the recent review on somatic genome variation that addresses mosaic aneuploidy generation mechanisms [37], any disturbance occurring at molecular, supramolecular or intercellular level, can be associated with mitotic NDJ or other types of mitotic errors leading to aneuploidy. Among the most common causes of chromosome missegregation, different defects in kinetochore apparatus are suggested. Of them, merotelic kinetochore-microtubule attachment is considered as one of the commonest mechanism [37].

Up to now, there was lack of sufficient information on parental and cell division origin of trisomic line in asymptomatic GM carriers. Based on an estimation from maternal ages of the normal, mosaic and nonmosaic trisomic individuals, Richards [22] proposed that unlike mosaic DS, a large proportion of asymptomatic mosaic carriers started as normal zygotes. Since then, no studied were conducted for testing this hypothesis. In the present study, the majority of the mosaic parents were found to be a product of trisomic zygotes.

Mosaicism transmission or genetic predisposition to nondisjunction

Surprisingly, the data collected give evidence for a high frequency of mosaic 46/47,+21 offspring in carriers of GM. In 80 studied families, seven families with eight affected mosaic females were identified. There is no appropriate explanation for the high prevalence of mosaic females among affected offspring of GM carriers. Both genetic predisposition to NDJ [11] and sex-specific rescue due to either sex-specific chromosome loss [38] or sex-specific selection against abnormal cell line [39] can be suggested.

Mosaicism for a normal line is not frequently found either in postnatally or in prenatally detected trisomics, accounting for only 1-3% of all free T21 cases [17, 18, 40]. In contrast to a significant male excess typical to DS individuals with non-mosaic T21 (SR~1.3), a notable female prevalence was reported for carriers of mosaicism, being higher in prenatally detected cases (SR = 0.6) than in newborns (SR = 0.95) [17, 18, 40]. Therefore, both the high frequency of the "inherited" mosaicism and the strong female prevalence among mosaic offspring of carriers of germ-line mosaicism found in the present study were not expected.

Five cases of unaffected carriers of mosaicism for T21 in two successive generations were also reported, including two families with asymptomatic mosaicism "inherited" by a healthy GM carrier [10, 41], one family with non-DS mosaic child with xeroderma pigmentosum [11], and two nuclear families from a pedigree with recurrent T21 where several healthy family members were found to have uniparental disomy (UPD) of chromosome 21 [42]. The latter most probably indicates presence of GM in three generations, in the mother of two fetuses with T21 (case II/2), in her father (case III/1) and in his sister (case I/2), and in one of her paternal grandparents. Additionally, in some families where the individuals with T21 were second-degree and third-degree relatives, undetected GM could not be excluded [43]. One may suggest that the trisomic fetus in the family RDS-15 from the same study, who was identified as a product of meiosis II/mitotic NDJ of a paternal chromosome (bbd), inherited two chromosomes from his mosaic (bc/bbc) father, who in turn had inherited a trisomy from his mosaic mother (ab/abb), who also had given birth to twins with trisomy (abc). In the family RDS-19, the parents in whom NDJ in maternal meiosis I and in paternal meiosis II was identified were siblings. In this case, one may assume a grandmaternal GM (ab/abb) which was "transmitted" to her healthy mosaic daughter (bc/bbc) and to her son (bc/bbc) who gave birth to their offspring with non mosaic trisomy (bcd and bbe, respectively).

Summarizing, among 80 families, at least 12 families displaying mosaicism for T21 in successive generations were reported. There is most probably a bias towards publication of such cases. Higher numbers of families with trisomy 21 recurrence are needed for final evaluation of this phenomenon. Irrespective of the mechanisms of the mosaicism "transmission", this observation if confirmed in future studies, would indicate the relevance of cytogenetic testing of the unaffected offspring of GM carrier for the presence of mosaicism.

Sex ratio in carriers of gonadal mosaicism

Whatever mechanism accounts for the loss of an extra chromosome 21 from a trisomic conceptus, the remarkable feature of GM carriers is the female prevalence. There is a four-fold female preponderance in two unbiased epidemiological studies in which parental transmission of the extra chromosome was reported (16 maternally transmitted and four paternally transmitted trisomy 21 cases) [33, 44]. The proportion of female carriers of GM in this study (61 females and 19 males) is somewhat lower, probably because of a bias towards publishing "more interesting" cases of rare paternal transmission. Since corresponding impairment of spermatogenesis was not documented for carriers of GM for T21, some mechanisms other than reduced fertility in male carriers might be involved. Recent studies suggest that females may have GM for aneuploidy more often than males due to sex-specific chromosome loss in early embryogenesis [38].

Sex ratio in affected offspring

A male excess in Down syndrome patients with non-mosaic T21 is a well known but poorly understood phenomenon. The sex ratio in this group varies in different populations, the average being close to 1.3. A meta-analysis of data from epidemiological studies suggests that the phenomenon is not restricted to free trisomy 21 alone but also appears in translocation T21, in carriers of mutant or inherited unbalanced translocations [15]. Several mechanisms were proposed to explain the skewed sex ratio in DS: meiotic disturbance (non-homologous co-orientation in male meiosis), fertilization event (greater accessibility of Y-bearing sperm to ova disomic for chromosome 21), and post-fertilization events (intrauterine selection against females).

Non-homologous co-orientation of the chromosome 21 and the X chromosome in male meiosis which was proposed as a meiotic mechanism of joint segregation of the chromosome 21 and the Y-chromosome [12, 13, 15] still needs more supporting data. Besides, this mechanism can only explain the male prevalence in T21 of paternal origin which constitutes a minor part of all T21 cases [45]. Data from the present study indicate that meiotic events may not be responsible for the skewed sex ratio in DS since similar male preponderance was found in both maternally- and paternally transmitted T21.

Fertilization mechanisms suggest that Y-bearing sperm can promote non-disjunction in the ova [15, 16] or that a disomic ovum can be more readily fertilized by Y-carrying sperm [14]. However, both these mechanisms are not readily recognizable.

A comparison of the sex ratios in fetuses prenatally diagnosed with DS and in live births with DS suggests that there is no intrauterine selection favoring the survival of males [17, 18]. However, prenatally detected cases represent a highly mixed group, including those referred for advanced maternal ages, fetal serum markers, ultrasound abnormalities, parental anxiety, etc. As to GM carriers, the predominant indication for prenatal testing was "having a previous child with Down syndrome".

The data presented in this paper suggest that a probable explanation of the male prevalence in DS is an intrauterine selection against female fetuses. Recent mFISH study demonstrated a strong female prevalence among chromosomally abnormal miscarried fetuses [46]. According to Kuo [47], the combined factors of embryonic quality and endocrine dysfunction in female carriers of GM might contribute to miscarriages that are very common to these patients. Unfortunately the sample of both prenatally detected and miscarried T21 offspring collected in the present study is too small to allow a definitive conclusion on the ability of mosaic mothers to carry affected fetuses to term depending on the gender of the fetus. It should be noted though that there is no significant male prevalence in the unaffected offspring of female carriers of GM (18 males and 15 females, SR = 1.2).

Sex ratio in unaffected offspring

There is, however, a strong female excess among unaffected offspring of male carriers of GM, with 3 males and 11 females, the difference with unaffected offspring of female carriers of GM is significant, p = 0.037. Although the sample is small one might speculate about the genetic mechanism of such an unusual sex ratio. It might be a non homologous co-orientation of two chromosomes 21 with the X chromosome during the first meiotic division in the trisomic spermatocyte that leads to a preferential segregation of the X chromosome with one chromosome 21 and, consequently, to an excess of euploid females. However, a reciprocal strong excess of males among offspring with paternally derived T21, due to corresponding preferential segregation of the Y chromosome with two chromosomes 21, has not been observed. More families with paternal GM should be analyzed to confirm (or reject) this suggestion. Studies in sperm of male carriers might also contribute to understanding meiotic behavior of both the extra chromosome 21 and the sex chromosomes.

Maternal and grandmaternal ages

Maternal age is a well-established risk factor for non mosaic regular T21. However although women of 35 years and older have an elevated risk of having trisomic offspring, a comparatively low proportion of all DS births occurs to these women. Approximately 60% of all DS cases are born to young parents [48]. The underlying mechanism is still unclear, but parental germ-line mosaicism is one likely factor.

Analysis of publications reporting maternal age composition worldwide from 1970 to 1995 showed that in most of them the mean maternal age in DS mothers was reported to be higher than 30, fluctuating from 29.5 in Taiwan to 35.6 in Libya. In the majority of that reports, mean population maternal age did not exceed 27, varying from 24.4 in Northeast Brasil to 28.1 year in Libya [16]. In the present study, the majority of mothers were young at the time of birth/conception of their first offspring with Down syndrome; the average maternal age was 26.4 years old which is similar to the average maternal age in the general population. One may argue that the mother's age, being the "age at first born DS child or fetus" could be biased lower as compared to average age of mothers in the population. However the figure of 26.4 is considerably lower compared to average age in DS mothers ascertained because of having first DS child. In the collected sample, there are 51 cases for which a sufficient reproductive history and pregnancy outcome were known. Of them, in 17 cases the first born DS child was not the first born child. In this group, the proportion of mothers aged 35 years or older at the time of the DS birth was 6%, and the mean maternal age was 28.4, which is still lower compared to average age in DS mothers.

In agreement with previous reports [20, 49], grandmaternal age at the time when carriers of GM were born was significantly increased. This is consistent with the assumption that the trisomic line occurred frequently as a result of age-dependent meiotic error. GM carriers born to young parents probably start as diploid zygote followed by a mitotic NDJ. Postzygotic NDJ as a mechanism of T21 formation was proven not to be associated with advanced maternal age [50]. Unfortunately, the lack of information on both grandmaternal age and the nature of the trisomy in GM mosaicism carriers in the majority of the reported families did not allow analysis of the association between maternal age and the origin of trisomy in asymptomatic carriers of gonadal mosaicism.

Materials and methods

The data for this study were obtained from an extensive literature review. Only cases that presented information sufficient to infer a high probability of true parental GM, together with known sex of the affected offspring, were included in the study. Because of the rarity of published cases, every effort was made to identify as many of the published cases as possible, including cases published in abstract form. A few cases were retrieved from log-books of St. Petersburg Centre of Medical Genetics (SPCMG) and Leningrad Region Medical Genetics Unit (LRMG). Whenever possible, information on the parental ages at the DS birth/conception and at the transmitting GM carrier's birth, as well as information on the sex of the unaffected offspring, was retrieved from the reported cases. Collected data were analyzed using binomial test and Chi-square test with Yates correction.


Both direct (results of cytogenetic and molecular study of the origin of trisomic line) and indirect (advanced grandmaternal age on the side of GM carrier) evidences allow to assume that significant proportion of the mosaic parents had been conceived as trisomics. Female-specific trisomy rescue and genetic predisposition to postzygotic non-disjunction has been suggested as mechanisms of formation of both somatic mosaicism and GM. Typical male preponderance in affected nonmosaic offspring with either maternally- or paternally transmitted trisomy 21, indicates than meiotic events are not responsible for the skewed sex ratio in DS. However a female excess among unaffected offspring of male carriers of GM might be the result of meiotic non homologous co-orientation of chromosomes 21 and X in spermatogenesis.



The author is greatly indebted to Prof. Maj A. Hulten (University of Warwick, UK) for the critical review the manuscript and helpful comments.

Authors’ Affiliations

Scientific Research Centre at Saint-Petersburg State Pediatric Medical Academy under the Federal Agency of Health Care and Social Development, St Petersburg, Russian Federation


  1. Alberman E, Mutton D, Ide R, Nicholson A, Bobrow M: Down's syndrome births and pregnancy terminations in 1989 to 1993: preliminary findings. Br J Obstet Gynaecol 1995, 102: 445–447.PubMedView ArticleGoogle Scholar
  2. Hassold T, Hall H, Hunt P: The origin of human aneuploidy: where we have been, where we are going. Hum Mol Genet 2007,16(SpecN2):R203–208. 10.1093/hmg/ddm243PubMedView ArticleGoogle Scholar
  3. Kovaleva NV: Parental mosaicism for trisomy 21. Problems with its detection and an approach to determining its population rate. Genet Test 2007, 11: 342–345. 10.1089/gte.2006.0515View ArticleGoogle Scholar
  4. Hulten MA, Patel SD, Tankimanova M, Westgren M, Papadogiannakis N, Jonsson AM, Iwarsson E: On the origin of trisomy 21 Down syndrome. Mol Cytogenet 2008, 1: 21. 10.1186/1755-8166-1-21PubMed CentralPubMedView ArticleGoogle Scholar
  5. Gair JL, Arbour L, Rupps R, Jiang R, Bruyere H, Robinson WP: Recurrent trisomy 21: four cases in three generations. Clin Genet 2005, 68: 430–435. 10.1111/j.1399-0004.2005.00512.xPubMedView ArticleGoogle Scholar
  6. Freeman SB, Allen EG, Oxford-Wright CL, Tinker SW, Druschel C, Hobbs CA, O'Leary LA, Romitti PA, Royle MH, Torfs CP, Sherman SL: The National Down syndrome project: design and implementation. Publ Health Rep 2007, 122: 62–72.Google Scholar
  7. Sherman SL, Freeman SB, Allen EG, Lamb NE: Risk factors for nondisjunction of trisomy 21. Cytogenet Genome Res 2005, 111: 273–280. 10.1159/000086900PubMedView ArticleGoogle Scholar
  8. Kovaleva NV: Problems of chromosome 21 mosaicism. A review. Tsitologiia 2003, 45: 434–439.PubMedGoogle Scholar
  9. Parke JC Jr, Grass FS, Pixley R, Deal J: Trisomy 21 mosaicism in two successive generations in a family. J Med Genet 1980, 17: 48–49. 10.1136/jmg.17.1.48PubMed CentralPubMedView ArticleGoogle Scholar
  10. Werner W, Herrmann FH, John B: Cytogenetic studies of a family with trisomy 21 mosaicism in two successive generations as the cause of Down's syndrome. Hum Genet 1982, 60: 202–204. 10.1007/BF00569714PubMedView ArticleGoogle Scholar
  11. Casati A, Giorgi R, Lanza A, Raimondi E, Vagnarelli P, Mondello C, Ghetti P, Piazzi G, Nuzzo F: Trisomy 21 mosaicism in two subjects from two generations. Ann Genet 1992, 35: 245–250.PubMedGoogle Scholar
  12. Kovaleva NV: Distributive pairing and aneuploidy in man. Genetika 1992, 28: 5–15.PubMedGoogle Scholar
  13. Petersen MB, Antonarakis SE, Hassold TJ, Freeman SB, Sherman SL, Avramopoulos D, Mikkelsen M: Paternal nondisjunction in trisomy 21: excess of male patients. Hum Mol Genet 1993, 2: 1691–1695. 10.1093/hmg/2.10.1691PubMedView ArticleGoogle Scholar
  14. Ferguson-Smith MA, Yates JRW: Maternal age-specific rates for chromosome aberrations and factors influencing them: report of a collaborative European study on 52 965 amniocenteses. Prenat Diagn 1984,4(Special):5–45. 10.1002/pd.1970040704PubMedView ArticleGoogle Scholar
  15. Kovaleva NV: Sex ratio in Down syndrome. A review. Tsitol Genet 2002,36(6):54–69.PubMedGoogle Scholar
  16. Kovaleva NV, Mutton DE: Epidemiology of double aneuploidies involving chromosome 21 and the sex chromosomes. Am J Med Genet A 2005, 134A: 24–32. 10.1002/ajmg.a.30306PubMedView ArticleGoogle Scholar
  17. Huether CA, Martin RLM, Stoppelman SM, D'Souza S, Bishop JK, Torfs CP, Lorey F, May KM, Hanna JS, Baird PA, Kelley JC: Sex ratios in fetuses and liveborn infants with autosomal aneuploidy. Am J Med Genet 1996, 63: 492–500. 10.1002/(SICI)1096-8628(19960614)63:3<492::AID-AJMG15>3.0.CO;2-HPubMedView ArticleGoogle Scholar
  18. Hook EB, Cross PK, Mutton DE: Female predominance (low sex ratio) in 47,+21 mosaics. Am J Med Genet 1999, 84: 316–319. 10.1002/(SICI)1096-8628(19990604)84:4<316::AID-AJMG2>3.0.CO;2-1PubMedView ArticleGoogle Scholar
  19. Penrose LS: Studies on mosaicism in Down's anomaly. In Mental Retardation. Edited by: Jervis GA. Springfield, III: Charles C. Thomas; 1967.Google Scholar
  20. Richards BW: Observations on mosaic parents of mongol propositi. J Ment Defic Res 1970, 14: 342–346.PubMedGoogle Scholar
  21. Mattei JF: Etude génétique des parents d'enfants trisomiques 21. Thése Médecine, Marseille 1974.Google Scholar
  22. Richards BW: Investigation of 142 mosaic mongols and mosaic parents of mongols. Cytogenetic analysis and maternal age at birth. J Ment Defic Res 1974, 18: 199–208.PubMedGoogle Scholar
  23. Harris DJ, Begleiter ML, Chamberlin J, Hankins L, Magenis RE: Parental trisomy 21 mosaicism. Am J Hum Genet 1982, 34: 125–133.PubMed CentralPubMedGoogle Scholar
  24. Katz-Jaffe MG, Trounson AO, Cram DS: Mitotic errors in chromosome 21 of human preimplantation embryo are associated with non-viability. Mol Hum Reprod 2004, 10: 143–147. 10.1093/molehr/gah017PubMedView ArticleGoogle Scholar
  25. Sandalinas M, Sadowy S, Alikani M, Calderon G, Cohen J, Munné S: Developmental ability of chromosomally abnormal human embryos to develop to the blastocyst stage. Hum Reprod 2001, 16: 1954–1958. 10.1093/humrep/16.9.1954PubMedView ArticleGoogle Scholar
  26. Shi Q, Adler I-D, Zhang J, Zhang X, Shan X, Martin R: Incidence of mosaic cell lines in vivo and malsegregation of chromosome 21 in lymphocytes in vitro of trisomy 21 patients: detection by fluorescence in situ hybridization on binucleate lymphocytes. Hum Genet 2000, 106: 29–35. 10.1007/s004390051005PubMedView ArticleGoogle Scholar
  27. Soler A, Margarit E, Carrio A, Costa D, Queralt R, Ballesta F: Trisomy/tetrasomy 21 mosaicism in CVS: interpretation of cytogenetic discrepancies between placental and fetal chromosome complements. J Med Genet 1999, 36: 333–334.PubMed CentralPubMedGoogle Scholar
  28. Nielsen KG, Poulsen H, Mikkelsen M, Steuber E: Multiple recurrence of trisomy 21 Down syndrome. Hum Genet 1988, 78: 103–105. 10.1007/BF00291249PubMedView ArticleGoogle Scholar
  29. Butomo IV, Kovaleva NV: Structural chromosomal rearrangements and mosaicism in parents of children with Down's syndrome. Tsitol Genet 1993, 27: 87–91.PubMedGoogle Scholar
  30. Ives EJ, Allderdice PW, Bridge PJ, Barrett IJ, Kalousek DK, Connolly-Wilson MJ, Crowley MR: A mosaic trisomy 21 woman with seven trisomy 21 and no cytogenetically normal pregnancies. Am J Hum Genet 1997,61(suppl 4):A128.Google Scholar
  31. Uehara S, Yaegashi N, Maeda T, Hoshi N, Fujimoto S, Fujimori K, Yanagida K, Yamanaka M, Hirahara F, Yajima A: Risk of recurrence of fetal chromosomal aberrations: analysis of trisomy 21, trisomy 18, trisomy 13, and 45,X in 1,076 Japanese mothers. J Obstet Gynaecol Res 1999, 25: 373–379.PubMedView ArticleGoogle Scholar
  32. Taylor AI: Further observation of cell selection in vitro in normal/G trisomic mosaics. Nature 1970, 227: 163–164. 10.1038/227163a0PubMedView ArticleGoogle Scholar
  33. Uchida IA, Freeman VCP: Trisomy 21 Down syndrome. Parental mosaicism. Hum Genet 1985, 70: 246–248. 10.1007/BF00273450PubMedView ArticleGoogle Scholar
  34. Sachs ES, Jahoda MGJ, Los FJ, Pijpers L, Wladimiroff JW: Trisomy 21 mosaicism in gonads with unexpectedly high recurrence risk. Am J Med Genet 1990, (Suppl 7):186–188. 10.1002/ajmg.1320370737Google Scholar
  35. Tseng L-H, Chuang SM, Lee T-Y, Ko T-M: Recurrent Down's syndrome due to maternal ovarian trisomy 21 mosaicism. Arch Gynecol Obstet 1994, 255: 213–216. 10.1007/BF02335088PubMedView ArticleGoogle Scholar
  36. Cozzi J, Coun CM, Harper J, Winston RML, Rindl M, Farndon PA, Delhanty JDA: A trisomic germ cell line and precocious chromatid segregation leads to recurrent trisomy 21 conception. Hum Genet 1999, 104: 23–28. 10.1007/s004390050905PubMedView ArticleGoogle Scholar
  37. Iourov IY, Vorsanova SG, Yurov YB: Intercellular genomic (chromosomal) variations resulting in somatic mosaicism: mechanisms and consequences. Curr Genomics 2006, 7: 435–446. 10.2174/138920206779116756View ArticleGoogle Scholar
  38. Kovaleva NV: Sex-specific instability in early human development. Am J Med Genet 2005, 136A: 401–413. 10.1002/ajmg.a.30815PubMedView ArticleGoogle Scholar
  39. Kovaleva NV, Cotter PD: Mosaicism for unbalanced structural autosome rearrangement: better prognosis for male carriers. Eur J Hum Genet 2005,13(Suppl 1):171.Google Scholar
  40. Mutton D, Alberman E, Hook EB: Cytogenetic and epidemiological findings in Down syndrome, England and Wales 1989 to 1993. J Med Genet 1996, 33: 387–394. 10.1136/jmg.33.5.387PubMed CentralPubMedView ArticleGoogle Scholar
  41. Buzhievskaia TI, Chaĩkovskaia TL, Skiban GV, Zerova-Liubimova TE, Kochubeĩ TP: Unusual cases of inheritance of Down's syndrome. Tsitol Genet 1988, 22: 25–29.PubMedGoogle Scholar
  42. Ban Z, Nagy B, Papp C, Beke A, Toth-Pal E, Papp Z: Recurrent trisomy 21 and uniparental disomy 21 in a family. Fetal Diagn Ther 2003, 18: 454–458. 10.1159/000073142PubMedView ArticleGoogle Scholar
  43. Pangalos CG, Talbot CC Jr, Lewis JG, Adelsberger PA, Petersen MB, Serre JL, Rethore MO, de Blois MC, Parent P, Schinzel AA, Binkert F, Boue J, Corbin E, Croquette MF, Gilgenkrantz S, de Grouchy J, Bertheas MF, Prieur M, Raoul O, Serville F, Siffroi PJ, Thepot F, Lejeune J, Antonarakis SE: DNA polymorphism analysis in families with recurrence of free trisomy 21. Am J Hum Genet 1992, 51: 1015–1027.PubMed CentralPubMedGoogle Scholar
  44. Kovaleva NV, Butomo IV, Verlinskaya DK, Ilyashenko TN, Pantova IG, Prozorova MV, Khitrikova LE, Shandlorenko SK: Karyological characterization of Down syndrome: clinical and theoretical aspects. Tsitologiia 1999, 41: 1014–1021.PubMedGoogle Scholar
  45. Petersen MB, Mikkelsen M: Nondisjunction in trisomy 21: origin and mechanisms. Cytogenet Cell Genet 2000, 91: 199–203. 10.1159/000056844PubMedView ArticleGoogle Scholar
  46. Vorsanova SG, Kolotii AD, Iourov IY, Monakhov VV, Kirillova EA, Soloviev IV, Yurov YB: Evidence for high frequency of chromosomal mosaicism in spontaneous abortions revealed by interphase FISH analysis. J Histochem Cytochem 2005, 53: 375–380. 10.1369/jhc.4A6424.2005PubMedView ArticleGoogle Scholar
  47. Kuo P-L: Maternal trisomy 21 mosaicism and recurrent spontaneous abortion. Fertil Steril 2002, 78: 432–433. 10.1016/S0015-0282(02)03217-XPubMedView ArticleGoogle Scholar
  48. Huether CA, Ivanovich J, Goodwin BS, Krivchenia EL, Hertzberg VS, Edmond LD, May DS, Priest JH: Maternal age specific risk rate estimates for Down Syndrome among live births in whites and other races from Ohio and Metropolitan Atlanta, 1970–1989. J Med Genet 1998, 35: 482–490. 10.1136/jmg.35.6.482PubMed CentralPubMedView ArticleGoogle Scholar
  49. Aagesen L, Grinsted J, Mikkelsen M: Advanced grandmaternal age on the mother's side: a risk of giving rise to trisomy 21. Ann Hum Genet 1984, 48: 297–301. 10.1111/j.1469-1809.1984.tb00843.xPubMedView ArticleGoogle Scholar
  50. Antonarakis SE, Avramopoulos D, Blouin J-L, Talbot C Jr, Schinzel AA: Mitotic errors in somatic cells cause trisomy 21 in about 4.5% of cases and are not associated with advanced maternal age. Nature Genet 1993, 3: 146–150. 10.1038/ng0293-146PubMedView ArticleGoogle Scholar
  51. Aarskog D: Down's syndrome transmitted through maternal mosaicism. Acta Paediatr Scand 1969, 58: 609–614. 10.1111/j.1651-2227.1969.tb04769.xPubMedView ArticleGoogle Scholar
  52. Blank CE, Gemmel E, Casey MD, Lord M: Mosaicism in a mother with a mongol child. Br Med J 1962, 2: 378–380. 10.1136/bmj.2.5301.378PubMed CentralPubMedView ArticleGoogle Scholar
  53. Bruyére H, Rupps R, Kuchinka BD, Friedman JM, Robinson WP: Recurrent trisomy 21 in a couple with a child presenting trisomy 21 mosaicism and maternal uniparental disomy for chromosome 21 in the euploid cell line. Am J Med Genet 2000, 94: 35–41. 10.1002/1096-8628(20000904)94:1<35::AID-AJMG8>3.0.CO;2-9PubMedView ArticleGoogle Scholar
  54. Cui Y-X, Hao L-J, Wang Y-H, Xia X-Y, Shi Y-C, Lu H-Y, Yao B, Huang YF: Second pregnancy of trisomy 21 in a mother with mosaicism. Chin Med J 2007, 120: 1295–1296.PubMedGoogle Scholar
  55. Dhadial R, Pfeiffer RA: Cytogenetic studies in families with two 47,+21 siblings. J Genet Hum 1972, 20: 297–322.PubMedGoogle Scholar
  56. English C, Hammersley AL, Jackson A, Stenhouse S, Cross IE: Recurrent trisomy 21 resulting from gonadal mosaicism. J Med Genet 2001,38(suppl 1):S48.Google Scholar
  57. Ferrier S: Enfant mongolien - parent mosaïque. Etude de deux families. J Genet Hum 1964, 13: 315–336.PubMedGoogle Scholar
  58. Fitzgerald PH, Archer SA, Morris CM: Evidence for the repeated primary non-disjunction of chromosome 21 as a result of premature centromere division. Hum Genet 1986, 72: 58–62. 10.1007/BF00278818PubMedView ArticleGoogle Scholar
  59. Frias S, Ramos S, Molina B, del Castillo V, Mayen DG: Detection of mosaicism in lymphocytes of parents of free trisomy 21 offspring. Mutat Res 2002, 520: 25–37.PubMedView ArticleGoogle Scholar
  60. Fujita N, Shirahata Y, Takata M, Ynagi Y, Nakajina H, Tamura S: A case of multiple recurrence of trisomy 21. Jpn J Hum Genet 1992,37(1):71S.Google Scholar
  61. Gomirato-Sandrucci M, Fabris C, Franceschini P: Familial mongolism Mosaicism (47,XX,G+/46,XX) in a mother with two mongol children. In Proc XIII Int Congr Pediatrics, Wien, 29 Aug - 4 Sept 1971. Volume 5. Wiener Medizinishen Academie; 57–68.Google Scholar
  62. Goodwin BA, Kousseff BG: Double satellites and mosaicism: counseling dilemmas. Am J Hum Genet 1986,39(Suppl 3):A177.Google Scholar
  63. Izakovič V, Getlik A: Mozaika 46,XX/47,XX,G+ matky dietata s Downovym syndromom-trizomiou G 1 . Cesk Pediatr 1969, 24: 698–701.PubMedGoogle Scholar
  64. James RS, Ellis K, Pettay D, Jacobs PA: Cytogenetic and molecular study of four couples with multiple trisomy 21 pregnancies. Eur J Hum Genet 1998, 6: 207–212. 10.1038/sj.ejhg.5200178PubMedView ArticleGoogle Scholar
  65. Kaffe S, Hsu LYF, Hirschhorn K: Trisomy 21 mosaicism in a woman with two children with trisomy 21 Down syndrome. J Med Genet 1974, 11: 378–381. 10.1136/jmg.11.4.378PubMed CentralPubMedView ArticleGoogle Scholar
  66. Kovaleva NV, Tahmasebi-Hesari M: Detection of gonadal mosaicism in parents of offspring with Down syndrome. Tsitol Genet 2007,41(5):36–42.PubMedGoogle Scholar
  67. Krishna Murthy DS, Farag TI: Recurrent regular trisomy 21 in two Bedoin families. Parental mosaicism versus genetic predisposition. Ann Genet 1995, 38: 217–224.PubMedGoogle Scholar
  68. Krmpotic E, Hardin MB: Secondary nondisjunction causing regular trisomy 21 in the offspring of a mosaic trisomy 21 mother. Am J Obstet Gynecol 1971, 110: 589–590.PubMedGoogle Scholar
  69. Makino S: Chromosome studies in patients with congenital and hereditary diseases, developmental deficiencies and sexual abnormalities. Cytologia (Tokyo) 1964, 29: 125.View ArticleGoogle Scholar
  70. Mikkelsen M: A Danish survey of patients with Down's syndrome born to young mothers. Ann NY Acad Sci 1970, 171: 370–378. 10.1111/j.1749-6632.1970.tb39345.xView ArticleGoogle Scholar
  71. MRCC, Medical Research Council of Canada: Diagnosis of genetic disease by amniocentesis during the second trimester of pregnancy. MRCC 1977, Report No. 5. Supply Services, Ottawa, Canada Google Scholar
  72. Nuzzo F, Stefanini M, Simoni G, Larizza L, Mottura A, Reali E, Franceschini P: A family with three sibs carrying trisomy 21. Ann Genet 1975, 18: 111–116.PubMedGoogle Scholar
  73. Osuna A, Moreno A: Regular Q21-trisomy in 3 sibs from mother with trisomy 21 mosaicism. J Med Genet 1977, 14: 286–287. 10.1136/jmg.14.4.286PubMed CentralPubMedView ArticleGoogle Scholar
  74. Raichs A, Tamparillas M: Down syndrome in a boy with mosaicism 46,XY,i(21)/47,XY,+21 and mosaicism 46,XX/47,XX,+21 in his mother. Sangre (Barc) 1967, 12: 71–80.Google Scholar
  75. Rowe IF, Ridler MAC, Gibberd FB: Presenile dementia associated with mosaic trisomy 21 in a patient with a Down syndrome child. Lancet 1989, 2: 229. 10.1016/S0140-6736(89)90421-2PubMedView ArticleGoogle Scholar
  76. Smith DW, Therman EM, Patau KA, Inhorn SL: Mosaicism in mother of two mongols. Am J Dis Child 1962, 104: 534.Google Scholar
  77. Street ML, Barber JCK, Boyle TA, Ellis KH, Bullman H, Homfray T: Parental mosaic trisomy 21 detected following maternal cell contamination of an amniotic fluid specimen from a normal male pregnancy. Prenat Diagn 2007, 27: 858–860. 10.1002/pd.1782PubMedView ArticleGoogle Scholar
  78. Sutherland GR, Fitzgerald MG, Danks DM: Difficulty in showing mosaicism in the mother of three mongols. Arch Dis Child 1972, 47: 970–971. 10.1136/adc.47.256.970PubMed CentralPubMedView ArticleGoogle Scholar
  79. Timson J, Harris R, Gadd RL, Ferguson-Smith ME, Ferguson-Smith MA: Down's syndrome due to maternal mosaicism, and the value of antenatal diagnosis. Lancet 1971, 1: 549–550. 10.1016/S0140-6736(71)91153-6PubMedView ArticleGoogle Scholar
  80. Verresen H, Van den Berghe H, Creemers J: Mosaic trisomy in phenotypically normal mother of a mongol. Lancet 1964, 1: 526–527. 10.1016/S0140-6736(64)92912-5PubMedView ArticleGoogle Scholar
  81. Weinstein ED, Warkany J: Maternal mosaicism and Down's syndrome (mongolism). J Pediatr 1963, 63: 599–604. 10.1016/S0022-3476(63)80370-4PubMedView ArticleGoogle Scholar
  82. Domány Z, Metnéki J: Mosaik-Trisomie bei den vätern von zwei kindern mit Down-syndrome. Acta Paediatr Acad Sci Hung 1976, 17: 177–181.PubMedGoogle Scholar
  83. Hsu LYF, Gertner M, Leiter E, Hirschhorn K: Paternal trisomy 21 mosaicism and Down syndrome. Am J Hum Genet 1971, 23: 592–601.PubMed CentralPubMedGoogle Scholar
  84. Massimo L, Borrone C, Vianello MG, Dagna Bricarelli F: Familial immune defects. Lancet 1967, 1: 108. 10.1016/S0140-6736(67)92506-8View ArticleGoogle Scholar
  85. Mehés K: Paternal trisomy 21 mosaicism and Down's anomaly. Humangenetik 1973, 17: 297–300.PubMedGoogle Scholar
  86. Papp Z, Csecsei K, Skapinyecz J, Dolhay B: Paternal normal-trisomy 21 mosaicism as an indication for amniocentesis. Clin Genet 1974, 6: 192–194.PubMedView ArticleGoogle Scholar
  87. Soltan HC, Wiens RG, Sergovich FP: Genetic studies and chromosomal analyses in families with mongolism (Down's syndrome) in more than one member. Acta Genet (Basel) 1964, 14: 251–264.Google Scholar
  88. De Toni E, Massimo L, Vianello MG, Dagna-Bricarelli F: Differenti aspetti di aberrazioni cromosomiche. Minerva pediat 1967, 19: 699–702.PubMedGoogle Scholar
  89. Walker FA, Ising R: Mosaic Down's syndrome in a father and daughter. Lancet 1969, 1: 374. 10.1016/S0140-6736(69)91340-3PubMedView ArticleGoogle Scholar


© Kovaleva; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.